323 related articles for article (PubMed ID: 18338241)
1. Development of stable influenza vaccine powder formulations: challenges and possibilities.
Amorij JP; Huckriede A; Wilschut J; Frijlink HW; Hinrichs WL
Pharm Res; 2008 Jun; 25(6):1256-73. PubMed ID: 18338241
[TBL] [Abstract][Full Text] [Related]
2. Preservation of the immunogenicity of dry-powder influenza H5N1 whole inactivated virus vaccine at elevated storage temperatures.
Geeraedts F; Saluja V; ter Veer W; Amorij JP; Frijlink HW; Wilschut J; Hinrichs WL; Huckriede A
AAPS J; 2010 Jun; 12(2):215-22. PubMed ID: 20195930
[TBL] [Abstract][Full Text] [Related]
3. Development of a Freeze-Dried, Heat-Stable Influenza Subunit Vaccine Formulation.
Flood A; Estrada M; McAdams D; Ji Y; Chen D
PLoS One; 2016; 11(11):e0164692. PubMed ID: 27851765
[TBL] [Abstract][Full Text] [Related]
4. Physical and immunogenic stability of spray freeze-dried influenza vaccine powder for pulmonary delivery: comparison of inulin, dextran, or a mixture of dextran and trehalose as protectants.
Murugappan S; Patil HP; Kanojia G; ter Veer W; Meijerhof T; Frijlink HW; Huckriede A; Hinrichs WL
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):716-25. PubMed ID: 23933147
[TBL] [Abstract][Full Text] [Related]
5. Comparison of adjuvants for a spray freeze-dried whole inactivated virus influenza vaccine for pulmonary administration.
Patil HP; Murugappan S; de Vries-Idema J; Meijerhof T; de Haan A; Frijlink HW; Wilschut J; Hinrichs WL; Huckriede A
Eur J Pharm Biopharm; 2015 Jun; 93():231-41. PubMed ID: 25896446
[TBL] [Abstract][Full Text] [Related]
6. Stabilization of Live Attenuated Influenza Vaccines by Freeze Drying, Spray Drying, and Foam Drying.
Lovalenti PM; Anderl J; Yee L; Nguyen V; Ghavami B; Ohtake S; Saxena A; Voss T; Truong-Le V
Pharm Res; 2016 May; 33(5):1144-60. PubMed ID: 26818839
[TBL] [Abstract][Full Text] [Related]
7. Novel dry powder preparations of whole inactivated influenza virus for nasal vaccination.
Garmise RJ; Staats HF; Hickey AJ
AAPS PharmSciTech; 2007 Oct; 8(4):E81. PubMed ID: 18181542
[TBL] [Abstract][Full Text] [Related]
8. Developments in the formulation and delivery of spray dried vaccines.
Kanojia G; Have RT; Soema PC; Frijlink H; Amorij JP; Kersten G
Hum Vaccin Immunother; 2017 Oct; 13(10):2364-2378. PubMed ID: 28925794
[TBL] [Abstract][Full Text] [Related]
9. Induction of protective immunity against H1N1 influenza A(H1N1)pdm09 with spray-dried and electron-beam sterilised vaccines in non-human primates.
Scherließ R; Ajmera A; Dennis M; Carroll MW; Altrichter J; Silman NJ; Scholz M; Kemter K; Marriott AC
Vaccine; 2014 Apr; 32(19):2231-40. PubMed ID: 24631078
[TBL] [Abstract][Full Text] [Related]
10. A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalation.
Saluja V; Amorij JP; Kapteyn JC; de Boer AH; Frijlink HW; Hinrichs WL
J Control Release; 2010 Jun; 144(2):127-33. PubMed ID: 20219608
[TBL] [Abstract][Full Text] [Related]
11. Dry influenza vaccines: towards a stable, effective and convenient alternative to conventional parenteral influenza vaccination.
Tomar J; Born PA; Frijlink HW; Hinrichs WL
Expert Rev Vaccines; 2016 Nov; 15(11):1431-1447. PubMed ID: 27118428
[TBL] [Abstract][Full Text] [Related]
12. Influenza vaccine powder formulation development: spray-freeze-drying and stability evaluation.
Maa YF; Ameri M; Shu C; Payne LG; Chen D
J Pharm Sci; 2004 Jul; 93(7):1912-23. PubMed ID: 15176078
[TBL] [Abstract][Full Text] [Related]
13. Dry Formulations Enhanced Mucoadhesive Properties and Reduced Cold Chain Handing of Influenza Vaccines.
Saengkrit N; Saesoo S; Woramongkolchai N; Sajomsang W; Phunpee S; Dharakul T; Ruktanonchai UR
AAPS PharmSciTech; 2018 Nov; 19(8):3763-3769. PubMed ID: 30259401
[TBL] [Abstract][Full Text] [Related]
14. Stabilization of HAC1 influenza vaccine by spray drying: formulation development and process scale-up.
Zhu C; Shoji Y; McCray S; Burke M; Hartman CE; Chichester JA; Breit J; Yusibov V; Chen D; Lal M
Pharm Res; 2014 Nov; 31(11):3006-18. PubMed ID: 24858396
[TBL] [Abstract][Full Text] [Related]
15. Stability of lyophilized and spray dried vaccine formulations.
Preston KB; Randolph TW
Adv Drug Deliv Rev; 2021 Apr; 171():50-61. PubMed ID: 33484735
[TBL] [Abstract][Full Text] [Related]
16. Development of a dried influenza whole inactivated virus vaccine for pulmonary immunization.
Audouy SA; van der Schaaf G; Hinrichs WL; Frijlink HW; Wilschut J; Huckriede A
Vaccine; 2011 Jun; 29(26):4345-52. PubMed ID: 21514345
[TBL] [Abstract][Full Text] [Related]
17. Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on Stability II: stability of a vaccine.
Abdul-Fattah AM; Truong-Le V; Yee L; Pan E; Ao Y; Kalonia DS; Pikal MJ
Pharm Res; 2007 Apr; 24(4):715-27. PubMed ID: 17372697
[TBL] [Abstract][Full Text] [Related]
18. Dried influenza vaccines: over the counter vaccines.
Saluja V; Hinrichs WL; Frijlink HW
Hum Vaccin; 2010 Oct; 6(10):854-6. PubMed ID: 20930565
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary immunization of chickens using non-adjuvanted spray-freeze dried whole inactivated virus vaccine completely protects against highly pathogenic H5N1 avian influenza virus.
Peeters B; Tonnis WF; Murugappan S; Rottier P; Koch G; Frijlink HW; Huckriede A; Hinrichs WL
Vaccine; 2014 Nov; 32(48):6445-50. PubMed ID: 25285885
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of monophosphoryl lipid A as adjuvant for pulmonary delivered influenza vaccine.
Patil HP; Murugappan S; ter Veer W; Meijerhof T; de Haan A; Frijlink HW; Wilschut J; Hinrichs WL; Huckriede A
J Control Release; 2014 Jan; 174():51-62. PubMed ID: 24269505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
